Physician profile
Travis Mason
NPI 1578720926
$8,250.87
in general payments reported to CMS, 2019-2025
10 companies · $2,809 in 2025
The $2,809 reported for 2025 was more than what 85% of Surgical Oncology providers received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $962 · 2022: $4,308 · 2023: $60.73 · 2024: $112 · 2025: $2,809.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,290 · Education: $1,000 · Food and Beverage: $691.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,289.76 |
| Education | $1,000.00 |
| Food and Beverage | $691.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,186.85 | 2021-2025 | |
| Histosonics, INC. | $372.40 | 2025 | |
| Medtronic, INC. | $190.70 | 2024-2025 | Signia |
| Boston Scientific Corporation | $157.02 | 2024-2025 | Axios, Overstitch Endoscopic Suturing System Sx |
| Tg Therapeutics, INC. | $117.25 | 2021 | |
| Glaxosmithkline, LLC. | $92.94 | 2021 | |
| Applied Medical Resources Corporation | $60.73 | 2023 | |
| Angiodynamics, INC. | $41.26 | 2025 | Smart Port Ct |
| Exelixis INC. | $17.92 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $13.80 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Travis Mason listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.